Overview
Takuya Fukazawa practices in Okayama, Japan. Mr. Fukazawa is rated as a Distinguished expert by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Squamous Cell Lung Carcinoma, Lung Cancer, Lung Adenocarcinoma, and Esophageal Cancer.
His clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Squamous Cell Lung Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Squamous Cell Lung CarcinomaMr. Fukazawa isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Lung CancerMr. Fukazawa isAdvanced. Learn about Lung Cancer.
- Experienced
- Birt-Hogg-Dube SyndromeMr. Fukazawa isExperienced. Learn about Birt-Hogg-Dube Syndrome.
- EGFR Positive Lung CancerMr. Fukazawa isExperienced. Learn about EGFR Positive Lung Cancer.
- Esophageal CancerMr. Fukazawa isExperienced. Learn about Esophageal Cancer.
- LiposarcomaMr. Fukazawa isExperienced. Learn about Liposarcoma.
- Lung AdenocarcinomaMr. Fukazawa isExperienced. Learn about Lung Adenocarcinoma.
- Lung MetastasesMr. Fukazawa isExperienced. Learn about Lung Metastases.